Effects of exogenous recombinant human bone morphogenic protein-7 on the corneal epithelial mesenchymal transition and fibrosisopen access
- Authors
- Chung, Jin Kwon; Park, Shin Ae; Hwang, Hee Sun; Kim, Kwang Sung; Cho, Yang Je; You, Yong Sung; Kim, Young Sik; Jang, Ju Woong; Lee, Sung Jin
- Issue Date
- 18-Mar-2017
- Keywords
- bone morphogenic protein-7; corneal fibrosis; epithelial mesenchymal transition; myodifferentiation; transforming growth factor-beta
- Citation
- International Journal of Ophthalmology, v.10, no.3, pp 329 - 335
- Pages
- 7
- Journal Title
- International Journal of Ophthalmology
- Volume
- 10
- Number
- 3
- Start Page
- 329
- End Page
- 335
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/7692
- DOI
- 10.18240/ijo.2017.03.01
- ISSN
- 2222-3959
2227-4898
- Abstract
- AIM: To evaluate the effect of exogenous recombinant human bone morphogenic protein-7 (rhBMP-7) on transforming growth factor-alpha (TGF-beta)-induced epithelial mesenchymal cell transition (EMT) and assessed its antifibrotic effect via topical application. METHODS: The cytotoxic effect of rhBMP-7 was evaluated and the EMT of human corneal epithelial cells (HECEs) was induced by TGF-beta. HECEs were then cultured in the presence of rhBMP-7 and/or hyaluronic acid (HA). EMT markers, fibronectin, E-cadherin, alpha-smooth muscle actin (alpha-SMA), and matrix metaloproteinase-9 (MMP-9), were evaluated. The level of corneal fibrosis and the reepithelization rate were evaluated using a rabbit keratectomy model. Expression of alpha-SMA in keratocytes were quantified following treatment with different concentrations of rhBMP-7. RESULTS: Treatment with rhBMP-7 attenuated TGF-beta-induced EMT in HECEs. It significantly attenuated fibronectin secretion (31.6%; P<0.05), the alpha-SMA protein level (72.2%; P<0.01), and MMP-9 expression (23.6%, P<0.05) in HECEs compared with cells grown in the presence of TGF-6 alone. E-cadherin expression was significantly enhanced (289.7%; P<0.01) in the presence of rhBMP-7. Topical application of rhBMP-7 combined with 0.1% HA significantly reduced the amount of alpha-SMA(+) cells by 43.18% (P<0.05) at a concentration of 2.5 mu g/mL and by 47.73% (P<0.05) at 25 mu g/mL, compared with the control group, without disturbing corneal reepithelization. CONCLUSION: rhBMP-7 attenuates TGF-beta-induced EMT in vitro, and topical application of rhBMP-7 reduces keratocyte myodifferentiation during the early wound healing stages in vivo without hindering reepithelization. Topical rhBMP-7 application as biological eye drops seems to be feasible in diseases involving TGF-beta-related comeal fibrosis with corneal reepithelization disorders.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Ophthalmology > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/7692)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.